From Feasibility to First Patient In: How to Streamline Study Start-Up

Clinical trial delays are often assumed to occur during study conduct, but in reality, many originate much earlier, during study start-up. This webinar explores how early decisions made during feasibility and country selection can significantly influence timelines, introducing risks before the first patient is even screened.

Drawing on real-world experience, this session demonstrates how shifting from a siloed, task-based approach to a fully integrated start-up strategy can improve predictability, strengthen execution, and accelerate time to First Patient In (FPI) without compromising quality.

Gain practical insights into aligning strategy with operational execution, embedding local expertise, and proactively managing risks across the start-up lifecycle.